New Indication: Skyrizi for Crohn Disease

Avatar photoSteve Duffy
|

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • 11

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

Skyrizi is now approved for the treatment of moderately to severely active Crohn disease in adults.

Learn more about this new indication with our slideshow, complete drug monograph, and downloadable PDF.

  • Latest News Your top articles for Tuesday

  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More